Qualitative Study About Psychedelics Using in Psychiatric Disorders
Not yet recruiting
- Conditions
- Psychiatric Disorder
- Interventions
- Diagnostic Test: Interview
- Registration Number
- NCT06014164
- Lead Sponsor
- University Hospital, Toulouse
- Brief Summary
This study is set up to better understand the current use of psychedelics in France in the general population. The present focus on individuals who have used any type of psychedelic drug in order to suppress or alleviate a psychiatric symptom in the context of a diagnosed pathology. The data are collected during a semi-structured interview and then studied in a thematic analysis.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 25
Inclusion Criteria
- Patients diagnosed with a psychiatric disorder by a psychiatrist or general practitioner
- Patients used psychedelic or related substances in order to treat psychiatric symptoms
- Patients have given their oral non-opposition
- Patients affiliated to a social security scheme
Exclusion Criteria
- Patients who don't speak or understand French
- Patients under protection, guardianship or curators
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Patients using psychedelic substances Interview Adult patients self-administering psychedelic substances in psychiatric disorders
- Primary Outcome Measures
Name Time Method Experiences of people using psychedelic substances Baseline Experiences description of people with psychiatric disorders who use psychedelic substances for therapeutic purposes will be assessed by interview
- Secondary Outcome Measures
Name Time Method Profile of people using psychedelic substances Baseline The profile of people with psychiatric disorders who use psychedelic substances for therapeutic purposes will be assessed by interview